Incyte Investigative Site

New Haven, Connecticut 06510

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
New Haven, CT
Click here to add this to my saved trials